EPIC Test Compendium Alpha
Welcome to the new Northwell Health Labs Test Directory, please call our Client Services Department at 1-800-472-5757 with any typos, corrections or issues.

CEBPA Mutation Analysis

Test Catalog Information

Test Catalog Synonyms
EPIC Synonyms
Cerner Primary MnemonicCEBPA Mut Analysis
EPIC Display NameCEBPA Mutation Analysis
Allscripts (AEHR) Order Name

AML - CEBPA Mutation Analysis

Sunrise Clinical Manager (SCM) Order Name

Not Orderable

EPIC Inpatient Orderable Yes
EPIC Outpatient Orderable Yes
Cerner Results Report Note
Test Information
Comments on Results
CEBPA Mutational Analysis
Key Results Comment
Electronic Sig
Methodology (BioRef)
Clinical Info
Footnotes
Disclaimer (BioRef)
Additional Report Reviews
References (BioRef)
Assoc Tests
Interpretive Info
Interpretation (BioRef)
Results (BioRef)
Clinical Info

In the context of normal cytogenetics AML patients with biallelic CEBPA mutations have a favorable prognosis. Risk adopted treatment strategies can be adopted for such patients.

Specimen Type

Container

Lavender Top Tube

Collection Instructions

Container/Tube:  Lavender top tube
Specimen: 2 mL Bone Marrow 
      Alternate Specimen: 
          5 mL Peripheral Blood - Lavender Top,Peripheral Blood - Green Top
Transport Temperature: Room Temperature
 
Note:   Sample must be at the lab within 24 hours
 
Patient history and diagnosis required

Transport Instructions

Room Temperature

Specimen Stability

Methodology

Polymerase Chain Reaction

Days Performed

Performing Laboratory

GeneDx

CPT

81403

PDM

1659852

Desired Epic Build CEBPA Mutation Analysis

Cerner Primary Mnemonic: CEBPA Mut Analysis
PDM 1659852
Informatics - WorkgroupMolecular-send outs
Synonyms *
Display Name *CEBPA Mutation Analysis
Order Entry Specimen Sources *
Order Entry Specimen Types
Blood
Specimen Navigator Specimen Types
Specimen Navigator Specimen Sources
Specimen Navigator Short Name
Ordering info (EPIC SmartText)In the context of normal cytogenetics AML patients with biallelic CEBPA mutations have a favorable prognosis. Risk adopted treatment strategies can be adopted for such patients.
IP Orderable Yes
OP Orderable Yes
AOEs *

AP AOEs
Special History No
Build Comments
Filter *genetics
Procedure Category Change
Cerner Results

Result DescResult displayResult PDM
Report Note Report Note 1659834M
Test Info Test Information 1659834E
Comm Results Comments on Results 1659834D
CEBPA Mut CEBPA Mutational Analysis 1659852A
Key Results Key Results Comment 1659834K
Electronic Sig Electronic Sig 1659834I
Method(BioRef) Methodology (BioRef) 1659834F
Clinical Info Clinical Info 1659834C
Footnotes Footnotes 1659834J
Disclaimer Disclaimer (BioRef) 1659834H
Add Rpt Review Additional Report Reviews 1659843D
Ref(BioRef) References (BioRef) 1659834G
Assoc Tests Assoc Tests 1659834L
Interp Info Interpretive Info 1659843B
Interp(BioRef) Interpretation (BioRef) 1659834A
Result(BioRef) Results (BioRef) 1659843C

Actual Epic build

Procedure Id 114870
Pdm 1659852
Order Display Name CEBPA Mutation Analysis
Procedure Name CEBPA MUT ANALYSIS
Procedure Master Number LAB11249
Short Procedure Name CEBPA MUT ANALYSIS
Category Code 1.0
Category Code Record Name LAB BLOOD ORDERABLES
Synonyms
Clinically Active Yes
Orderable Yes
Performable Yes
Filter Genomics Generic Genomics Procedure
Reference Link Url https://labs.northwell.edu/epic/test/114870
Ordering Instructions
Default Specimen Type Blood
Specimen Type Pick List Blood
Specimen Type List
Op Specimen Type List
Specimen Source Pick List Blood, Arterial Blood, Capillary Blood, Central Line Blood, Venous
Specimen Source Default - Male Blood, Venous
Specimen Source Default - Female Blood, Venous
Specimen Source List
Op Specimen Source List
Ip Lab Test Components For Report
Op Lab Test Components For Report
Order Questions []
Order Questions Record Name
Inpatient Order Questions []
Inpatient Order Questions Record Name
Order Specific Question Override
Inpatient Question Override
Location Restrict List Ip
Location Restrict List Ip Record Name
Location Restrict List Include Ip
Location Restrict List Op
Location Restrict List Op Record Name
Location Restrict List Includes Op
Edp Amb Order Specific Questions Record Name
Edp Ip Order Specific Questions Record Name
Edp Ip Specimen Source Blood, Venous Blood, Central Line Blood, Arterial Blood, Capillary
Edp Op Specimen Source
Edp Ip Specimen Type Blood
Edp Op Specimen Type
Derived Edp Ip Buttons S Blood, Capillary Blood, Venous Blood, Central Line Blood, Arterial
Derived Edp Ip Buttons T Blood
Derived Edp Op Buttons S
Derived Edp Op Buttons T
Ip Orderable 1
Op Orderable 1
EPIC OP AOEs

EPIC IP AOEs

EPIC Components (results)

Component IDComponent NameBase NameCommon NameExternal NameCerner Result PDM
3047805628.0 REPORT NOTE REPORTNOTE REPORTNOTE, NOTE 1659834M
3047804928.0 TEST INFORMATION TESTINFO TEST INFORMATION 1659834E
3047801938.0 COMMENTS ON RESULTS COMMENRES COMMENTS ON RESULTS 1659834D
3047801699.0 CEBPA MUTATIONAL ANALYSIS CEBPA CEBPA MUTATIONAL ANALYSIS 1659852A
3047803186.0 KEY RESULTS COMMENT COMMENT KEY RESULTS COMMENT 1659834K
3047802291.0 ELECTRONIC SIG ELECTSIG ELECTRONIC SIG 1659834I
3047803487.0 METHODOLOGY (BIOREF) METHOD METHODOLOGY (BIOREF) 1659834F
3047801843.0 CLINICAL INFO CLININFO CLINICAL INFO 1659834C
3047805494.0 FOOTNOTES FOOTNOTES FOOTNOTES 1659834J
3047802165.0 DISCLAIMER (BIOREF) DISCLAIMERBR DISCLAIMER (BIOREF) 1659834H
3047800867.0 ADDITIONAL REPORT REVIEWS ADDREPREV ADDITIONAL REPORT REVIEWS 1659843D
3047804492.0 REFERENCES (BIOREF) REFBIO REFERENCES (BIOREF) 1659834G
3047801206.0 ASSOC TESTS ASSOCTEST ASSOC TESTS 1659834L
3047803097.0 INTERPRETIVE INFO INTERP INTERPRETIVE INFO 1659843B
3047803088.0 INTERPRETATION (BIOREF) INTERP INTERPRETATION (BIOREF) 1659834A
3047804550.0 RESULTS (BIOREF) RESULTSBIO RESULTS (BIOREF) 1659843C